The Cell Site of the Immunological Defect in Tumor-Bearing Mice

Abstract

In vivo studies have shown that in spite of the reactive splenomegaly with lymphoid cell hyperplasia, which is a constant finding in tumor-bearing mice, the capacity of the spleen cells to respond to injected SRBC by hemolysin production is significantly impaired.